← Back to Investors

TMC Venture Fund

TMC Venture Fund is the venture capital arm of Texas Medical Center, the world's largest medical complex. The fund invests in healthcare and life sciences companies with connections to the TMC ecosystem, leveraging the resources of 60+ member institutions including MD Anderson, Baylor College of Medicine, and Houston Methodist.

Location
Houston, Texas, USA
Founded
2015
AUM
$150M+
Investment Range
$500K - $5M
Focus
biotech-focused
Fund Stages
seed, series-a, series-b

Investment Thesis

TMC Venture Fund invests in early-stage healthcare companies that can benefit from the Texas Medical Center ecosystem. They focus on companies developing innovative therapies, medical devices, diagnostics, and digital health solutions. Portfolio companies gain access to clinical expertise, patient populations, and partnership opportunities across TMC member institutions.

Team

Partners / Managing Directors

  • William McKeon - President & CEO, TMC
  • Emily Reiser - Managing Director, TMC Venture Fund

Other Key Team Members

  • Investment committee includes leaders from TMC member institutions
  • TMC Innovation team provides operational support

Focus Areas

  • Therapeutics
  • Medical Devices
  • Diagnostics
  • Digital Health
  • Healthcare IT
  • Precision Medicine
  • Oncology (leveraging MD Anderson partnership)

Notable Portfolio Companies

  • Early-stage healthcare companies across therapeutics and medtech
  • Companies spun out of TMC member institutions
  • Healthcare technology startups in TMC Innovation ecosystem

Strategic Value

  • Access to 60+ TMC member institutions
  • Clinical trial support and patient populations
  • Collaboration with MD Anderson Cancer Center
  • Partnership with Baylor College of Medicine
  • TMC³ collaborative research campus
  • TMC Biodesign accelerator program

Sources